预约演示
WestGene wins FDA approval for mRNA vaccine to treat certain cancers
2024-05-10
疫苗上市批准免疫疗法信使RNA
Chinese biotech WestGene announced an FDA approval for its mRNA therapeutic cancer vaccine. Credit: aslysun via Shutterstock.
Chinese biotech WestGeneinistration (FFDA has approved an mRNA therapeutic ccancervaccine developed by China-based biotech WestGene.
This deFood and Drug Administration (FDA)’s first approved mRNA therapeuticcancerne to treat Epstein Barr (EB)-virus-relateWestGenes.
The approval was based on results from investigator-initiated trials that evaluated the vacciEpstein Barr (EB)-virus-related cancersinoma (NPC) and natural killer T cell lymphoma.
EB virus is a part of the herpesvirus family and spreads primarily through bodily fluids. The illness infects mornasopharyngeal carcinoma (NPC) population but does not always lead to cancer, as detailed by Cancer Research UK. The virus has been linked with NPC, gastric cancer, lung cancer and other diseases. In a 10 May press release, WestGene highlighted liver cancer, oesophageal cancer, breast cancer and the aforementioned diseases as potential future indications for the vaccine.
The Chinese company has a pipeline that includes four infectious disease vaccines, seven anti-tumour immunotherapies, and three gene editing treatments amongst other therapies.cancerCancergastric cancerlung cancerWestGeneliver canceroesophageal cancerbreast cancer
See Also:Formosa and Tabuk sign deal for FDA-approved ophthalmic suspensiontumour
In 2010, the FDA approved Dendreon Pharmaceutical’s prostate cancer prophylactic Provenge (sipuleucel-T) as the first marketed therapeutic cancer vaccine. Since its approval, other therapeutic cancer vaccines have entered the US market, with eight being available in the US, according to GlobalData.
GlobalData is the parent company of Pharmaceutical Technology.
In 2021, Pfizer and BioNTech gained the first-ever FDA approval for an mRNA vaccine with Comirnaty (BNT162b2) as a preventative measure against Covid-19. Since this milestone, several preventive and therapeutic mRNA vaccines have been in development for a wide range of conditions.
Some pharmaceFDAcal companDendreon Pharmaceuticalappprostate cancerp vaccines for other infsipuleucel-Tases such as respiratory syncytial vcancerRSV), Influenza A, Influenza B and cytomegalovircancerle companies, including Moderna, Curevac, and Cartesian Therapeutics, are developing therapeutic mRNA vaccines for treating different cancers.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-Eureka LS:
全新生物医药AI Agent 覆盖科研全链路，让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。